Clinical studyAlendronate treatment of the postmenopausal osteoporotic woman: Effect of multiple dosages on bone mass and bone remodeling☆
References (31)
- et al.
Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy
Am J Med.
(1993) - et al.
Long-term calcitonin therapy in postmenopausal osteoporosis
Metabolism.
(1984) - et al.
Discontinuous calcitonin treatment of established osteoporosis-effects of withdrawal of treatment
Am J Med.
(1990) - et al.
Transbol I: Bone mass in women after withdrawal of estrogen/gestagen replacement therapy
Lancet
(1981) - et al.
Bone density at various sites for prediction of hip fractures
Lancet
(1993) Bisphosphonates: pharmacology and use in treatment of tumor-induced hypercalcemic and metastatic bone disease
Drugs.
(1991)- et al.
Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis
NEJM.
(1990) - et al.
Intermittent cyclical etidronate treatment of postmenopausal osteoporosis
NEJM
(1990) - et al.
Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results
Ann Intern Med.
(1974) - et al.
Bisphosphonates act on rat bone resorption through the mediation of osteoblasts
J Clin Invest.
(1993)
Quantitative morphometric evaluation of the inhibition activity of new aminobisphosphonates on bone resorption in the rat
Calcif Tissue Int.
(1986)
The effects of 2 year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates
J Clin Invest.
(1993)
The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women
J Clin Endocrinol Metab
(1993)
Monotoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine
J Bone Miner Res.
(1994)
Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis
J Bone Miner Res.
(1994)
Cited by (0)
- ☆
This work was supported by a grant from Merck Research Laboratories, Rahway, New Jersey.
Copyright © 1995 Published by Excerpta Medica Inc.